HER1-based vaccine: Simultaneous activation of humoral and cellular immune response.

Bergado Báez, Gretchen

HER1-based vaccine: Simultaneous activation of humoral and cellular immune response. [electronic resource] - Seminars in oncology 01 2018 - 75-83 p. digital

Publication Type: Journal Article; Review

1532-8708

10.1053/j.seminoncol.2018.05.002 doi


Cancer Vaccines--immunology
ErbB Receptors--immunology
Humans
Immunity, Cellular--drug effects
Immunity, Humoral--drug effects
Immunotherapy, Active--methods
Models, Immunological
Neoplasms--drug therapy
Treatment Outcome